Jianhua Yu
City Of Hope National Medical Center(US)Ministry of Education of the People's Republic of China(CN)Anhui University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)University of California, Irvine(US)Southern University of Science and Technology(CN)Soochow University(CN)Maryland Oncology Hematology(US)Precision Therapeutics (United States)(US)Parker Institute for Cancer Immunotherapy(US)Nanjing Drum Tower Hospital(CN)Dongguan People’s Hospital(CN)Wangjing Hospital of China Academy of Chinese Medical Sciences(CN)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)China Academy of Chinese Medical Sciences(CN)Cancer Services(US)Guhua Hospital(CN)Chongqing Medical University(CN)Nanjing University of Aeronautics and Astronautics(CN)
Publications by Year
Research Areas
Immune Cell Function and Interaction, CAR-T cell therapy research, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody(2010)798 cited
- → The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation(2020)794 cited
- → Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver(2012)776 cited
- → MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1(2009)769 cited
- → The Broad Spectrum of Human Natural Killer Cell Diversity(2017)678 cited
- → CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma(2013)439 cited